Posts tagged as

Martha Campbell-Thompson

Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β

Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting shared genetic components may contribute to both diseases. The cause of this association remains unknown. Mutations in disrupted in schizophrenia…

Predicting and preventing Type 1 diabetes

A new University of Florida pilot study is helping researchers better understand the trajectory of Type 1 diabetes and may one day help lead to interventions to prevent the disease.

Research Spotlight: Martha Campbell Thompson, PhD

A new discovery may provide a clue to why people develop Type 1 diabetes. The study, led by UF researcher Dr. Martha Campbell-Thompson, links pancreas size to diabetes risk. Researchers measured the weight of organ donors' pancreases and found that people diagnosed with Type 1 diabetes or who were at risk for the disease had smaller-sized pancreases.

NATCO 37th Annual Meeting

The NATCO Annual Meeting is the premier meeting where transplant and procurement practitioners join together to learn cutting-edge skills and collaborate with colleagues from all areas of their profession.